Related Experiment Video
Updated: Aug 17, 2026

Chromatin Immunoprecipitation Assay Using Micrococcal Nucleases in Mammalian Cells
Published on: May 10, 2019
CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate
Takayuki Ikezoe1, Sigal Gery, Dong Yin
1Division of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California, USA. ikezoet@med.kochi-ms.ac.jp
Abstract:
1,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the active metabolite of vitamin D3, inhibits the proliferation of prostate cancer cells. However, the molecular mechanisms by which 1,25(OH)2D3 inhibits the proliferation of these cells remain to be fully elucidated. In this study, we used microarray technology to identify target genes of 1,25(OH)2D3 in androgen-responsive prostate cancer LNCaP cells. 1,25(OH)2D3 up-regulated CCAAT/enhancer-binding protein delta (C/EBPdelta) by approximately 5-fold in these cells. Knockdown of C/EBPdelta expression by RNA interference showed that C/EBPdelta is essential for the significant growth inhibition of LNCaP cells in response to 1,25(OH)2D3 treatment. Moreover, we found that 1,25(OH)2D3 induced C/EBPdelta in other cancer cells, including the estrogen receptor (ER)-expressing MCF-7 and T47D breast cancer cells that are sensitive to the growth inhibitory effects of 1,25(OH)2D3. On the other hand, 1,25(OH)2D3 was not able to induce C/EBPdelta in either androgen receptor-negative PC-3 and DU145 or ER-negative breast cancer MDA-MB-231 cells that were relatively resistant to growth inhibition by 1,25(OH)2D3. Furthermore, forced expression of C/EBPdelta in prostate cancer LNCaP as well as breast cancer MCF-7 and T47D cells dramatically reduced their clonal growth. Taken together, forced expression of C/EBPdelta in cancer cells may be a promising therapeutic strategy.
Insights
The active vitamin D3 metabolite, 1,25(OH)2D3, inhibits prostate cancer growth by up-regulating CCAAT/enhancer-binding protein delta (C/EBPdelta). This protein is crucial for vitamin D3
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- 1,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the active form of vitamin D3, is known to inhibit prostate cancer cell proliferation.
- The precise molecular mechanisms underlying this inhibitory effect are not fully understood.
Purpose of the Study:
- To identify target genes of 1,25(OH)2D3 in prostate cancer cells using microarray analysis.
- To elucidate the role of CCAAT/enhancer-binding protein delta (C/EBPdelta) in the anti-proliferative effects of 1,25(OH)2D3.
Main Methods:
- Microarray technology was employed to identify genes modulated by 1,25(OH)2D3 in LNCaP prostate cancer cells.
- RNA interference was used to knock down C/EBPdelta expression.
- Forced expression of C/EBPdelta was performed in various cancer cell lines.
Main Results:
- 1,25(OH)2D3 significantly up-regulated C/EBPdelta by approximately 5-fold in LNCaP cells.
- Knockdown of C/EBPdelta abrogated the growth inhibitory effects of 1,25(OH)2D3 on LNCaP cells.
- 1,25(OH)2D3 induced C/EBPdelta in hormone-sensitive breast cancer cells (MCF-7, T47D) but not in hormone-insensitive cells (PC-3, DU145, MDA-MB-231).
- Forced expression of C/EBPdelta markedly reduced clonal growth in prostate and breast cancer cells.
Conclusions:
- C/EBPdelta is a key mediator of 1,25(OH)2D3-induced growth inhibition in prostate and breast cancer cells.
- The induction of C/EBPdelta by 1,25(OH)2D3 is dependent on the presence of specific hormone receptors (androgen or estrogen receptors).
- Therapeutic strategies involving the forced expression of C/EBPdelta show promise for cancer treatment.
Related Concept Videos
Cell Specific Gene Expression
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

